United States Facial Injectable Market Insights Forecasts to 2033

• The U.S. Facial Injectable Market Size was valued at USD 3.75 Billion in 2023.
• The Market is growing at a CAGR of 10.95% from 2023 to 2033
• The U.S. Facial Injectable Market Size is expected to reach USD 10.60 Billion by 2033

The United States Facial Injectable Market is anticipated to exceed USD 10.60 Billion by 2033, growing at a CAGR of 10.95% from 2023 to 2033. The growing adoption of aesthetic procedures and the rising geriatric population are driving the growth of the facial injectable market in the US.     

Market Overview

Facial injectable are intended to plump up the face, fill in hollows, and enhance volume. Neuromodulators, fat grafting, and dermal fillers are common injectables used for the face. Collagen and hyaluronic acid fillers, as well as synthetic fillers such as calcium hydroxylapatite, are items referred to as facial injectables. Through the improvement of the lips, elevation of scar depression, and reduction of wrinkles, facial injectables help to rejuvenate the skin on the face. Several aesthetic surgical treatments have an alternative in the form of facial injectables. Additionally, there are several benefits to these operations, including less trauma, discomfort, blood loss, and recovery time. The growing trend towards non-invasive treatments and progress in injectable technology is leveraging the market opportunities. The integration of artificial technology (AI) and advanced imaging technology in aesthetic practices which is encouraging more people to choose injectable face procedures leads to propel the market growth. Furthermore, the growing awareness among consumers of the ethical and environmental consequences of their decisions is leveraging the demand for cruelty-free, sustainably sourced, and eco-friendly products. 

Report Coverage

This research report categorizes the market for the US facial injectable market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States facial injectable market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the US facial injectable market.

Driving Factors

The need for the development of less invasive surgical techniques is rising due to the increased aging population in the US.  The industry's expansion is also greatly aided by the players' growing emphasis on creating demand-specific products with lower allergy risks. The growing emphasis on face appearance and the resulting increased awareness of aesthetic procedures are further driving the US facial injectable market.          

Restraining Factors

The increased cost and side effects associated with the use of facial injectables are restraining the US facial injectable market.

Market Segmentation

The United States Facial Injectable Market share is classified into type, application, and end user.

• The hyaluronic acid segment dominates the market with the largest market share in 2023.

The United States facial injectable market is segmented by type into botulinum toxin, collagen, hyaluronic acid, calcium hydroxylapatite, poly-L-lactic acid (PLLA), polymethyl-methacrylate microspheres (PMMA), fat injection, and others. Among these, the hyaluronic acid segment dominates the market with the largest market share in 2023. Hyaluronic acid is one injectable substance that improves skin hydration, shields it from UV rays, and has comparatively minimal adverse effects. The strong benefits linked to these products include improved patient safety and aesthetic outcomes are driving the market demand.

• The wrinkle reduction segment held the largest revenue share of the US facial injectable market in 2023.

The United States facial injectable market is segmented by application into wrinkle reduction, facelift, acne scar treatment, lipoatrophy treatment, lip enhancement, and others. Among these, the wrinkle reduction segment held the largest revenue share of the US facial injectable market in 2023. Facial fillers are injected into the skin to smooth out and minimize wrinkles. The rise in product approvals and investments in R&D of facial injectables are propelling market growth in the wrinkle reduction segment.

• The dermatology & cosmetic clinics segment dominated the US facial injectable market with the largest market share in 2023.       

Based on the end user, the U.S. facial injectable market is divided into hospitals & ASCs, dermatology & cosmetic clinics, and others. Among these, the dermatology & cosmetic clinics segment dominated the US facial injectable market with the largest market share in 2023. A lot of injectable operations for the face are carried out in dermatology and cosmetic clinics. The growing number of cases of aesthetic issues including wrinkles and facial volume loss, along with a greater public awareness of less invasive procedures support market growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the U.S. facial injectable market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• AbbVie, Inc.
• REVANCE AESTHETICS
• Galderma Laboratories, L.P.
• Merz North America, Inc.
• Cytophil, Inc
• Suneva Medical Inc.
• Prollenium Medical Technologies
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In May 2023, Evolus, Inc., a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced it has entered into a definitive agreement to be the exclusive U.S. distributor of a line of five unique dermal fillers currently in late-stage development.

Market Segment

This study forecasts revenue at U.S., regional, and country levels from 2020 to 2033. Spherical Insights has segmented the United States Facial Injectable Market based on the below-mentioned segments:

US Facial Injectable Market, By Type

• Botulinum Toxin
• Collagen
• Hyaluronic Acid
• Calcium Hydroxylapatite
• Poly-L-Lactic Acid (PLLA)
• Polymethyl-Methacrylate Microspheres (PMMA)
• Fat Injection
• Others

US Facial Injectable Market, By Application

• Wrinkle Reduction
• Facelift
• Acne Scar Treatment
• Lipoatrophy Treatment
• Lip Enhancement
• Others

US Facial Injectable Market, By End User

• Hospitals & ASCs
• Dermatology & Cosmetic Clinics
• Others